Now, drug industry players are feuding over the windfall. Amid public concern over spiking drug prices, a powerful middleman is suing a tiny drugmaker over unpaid rebates and fees. The maker calls the suit baseless; analysts say the suit offers a window into an opaque world

Quick Read

According to new genetic evidence published today, public health efforts to contain and fight the disease could have—and should have—gotten underway much sooner. Zika, it turns out, had established itself in Brazil as early as 2013

Quick Read

Several studies show beneficiaries of the program are more likely to be obese. But the answer is not to cut benefits, some academics say

Quick Read

Over the last 25 years, China, Ethiopia, the Maldive Islands, Peru, South Korea and Turkey had the greatest improvements in “deaths avoidable through health care at their economic level,” a complex but intriguing new measure of global mortality described last week in the Lancet

Quick Read

Listen now as our Travis Rieder joins the APA’s Medical Mind podcast to describe his experience of opioid withdrawal after a serious accident and outline a bioethical framework for opioid prescribing

Read More

“I was just totally gobsmacked,” says Brendan Saloner, an addiction researcher and faculty at the Johns Hopkins Berman Institute of Bioethics. Saloner says that Price’s own Department of Health and Human Services displays information online that contradicts his comments. The HHS website includes a link to the Substance Abuse and Mental Health Services Administration’s information page about medication-assisted treatment

Quick Read

Governments around the world were slow to get to grips with HIV/AIDS. But a big change came when they started understanding it not just as a health issue but as a security threat too. Alexandra Ossola investigates

Quick Read

Fall in cases brings end to the emergency 18 months after the virus hit headlines around the world

Quick Read